260 related articles for article (PubMed ID: 35681568)
1. Proton Therapy for Squamous Cell Carcinoma of the Head and Neck: Early Clinical Experience and Current Challenges.
Nuyts S; Bollen H; Ng SP; Corry J; Eisbruch A; Mendenhall WM; Smee R; Strojan P; Ng WT; Ferlito A
Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681568
[TBL] [Abstract][Full Text] [Related]
2. Proton therapy for head and neck squamous cell carcinomas: A review of the physical and clinical challenges.
Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gerard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Benezery K; Herault J; Poortmans P; Bourhis J; Thariat J;
Radiother Oncol; 2020 Jun; 147():30-39. PubMed ID: 32224315
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer.
Cripps C; Winquist E; Devries MC; Stys-Norman D; Gilbert R;
Curr Oncol; 2010 Jun; 17(3):37-48. PubMed ID: 20567625
[TBL] [Abstract][Full Text] [Related]
4. Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma.
Sumner W; Ray X; Sutton L; Rebibo D; Marincola F; Sanghvi P; Moiseenko V; Deichaite I
J Transl Med; 2021 May; 19(1):212. PubMed ID: 34001187
[TBL] [Abstract][Full Text] [Related]
5. [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].
Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gérard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Bénézery K; Hérault J; Bourhis J; Thariat J;
Cancer Radiother; 2019 Sep; 23(5):439-448. PubMed ID: 31358445
[TBL] [Abstract][Full Text] [Related]
6. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
Prasanna PG; Rawojc K; Guha C; Buchsbaum JC; Miszczyk JU; Coleman CN
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1325-1340. PubMed ID: 33640423
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
8. Comparative Therapeutic Exploitability of Acute Adaptation Mechanisms to Photon and Proton Irradiation in 3D Head and Neck Squamous Cell Carcinoma Cell Cultures.
Meerz A; Deville SS; Müller J; Cordes N
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33801853
[TBL] [Abstract][Full Text] [Related]
9. Proton therapy for head and neck cancer: rationale, potential indications, practical considerations, and current clinical evidence.
Mendenhall NP; Malyapa RS; Su Z; Yeung D; Mendenhall WM; Li Z
Acta Oncol; 2011 Aug; 50(6):763-71. PubMed ID: 21767172
[TBL] [Abstract][Full Text] [Related]
10. Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review).
Gordon KB; Smyk DI; Gulidov IA
Sovrem Tekhnologii Med; 2021; 13(4):70-80. PubMed ID: 34603766
[TBL] [Abstract][Full Text] [Related]
11. Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers.
Press RH; Bakst RL; Sharma S; Kabarriti R; Garg MK; Yeh B; Gelbum DY; Hasan S; Choi JI; Barker CA; Chhabra AM; Simone CB; Lee NY
Int J Part Ther; 2021; 8(1):248-260. PubMed ID: 34285951
[TBL] [Abstract][Full Text] [Related]
12. Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC).
Cohen RB
Cancer Treat Rev; 2014 May; 40(4):567-77. PubMed ID: 24216225
[TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials.
Poulose JV; Kainickal CT
World J Clin Oncol; 2022 May; 13(5):388-411. PubMed ID: 35662989
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Impact of HPV-Associated p16 Expression on Head and Neck Squamous Cell Carcinoma in Thai Patients.
Jiarpinitnun C; Larbcharoensub N; Pattaranutaporn P; Chureemas T; Juengsamarn J; Trachu N; Lukerak S; Chansriwong P; Ngamphaiboon N
Asian Pac J Cancer Prev; 2020 Jun; 21(6):1679-1687. PubMed ID: 32592364
[TBL] [Abstract][Full Text] [Related]
15. Proton radiotherapy and treatment delay in head and neck squamous cell carcinoma.
Jin MC; Harris JP; Sabolch AN; Gensheimer M; Le QT; Beadle BM; Pollom EL
Laryngoscope; 2020 Nov; 130(11):E598-E604. PubMed ID: 31837165
[TBL] [Abstract][Full Text] [Related]
16. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
17. Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma.
Lillo S; Mirandola A; Vai A; Camarda AM; Ronchi S; Bonora M; Ingargiola R; Vischioni B; Orlandi E
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893203
[TBL] [Abstract][Full Text] [Related]
18. Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma.
Suzuki S; Toyoma S; Kawasaki Y; Yamada T
PLoS One; 2022; 17(1):e0262549. PubMed ID: 35089951
[TBL] [Abstract][Full Text] [Related]
19. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison.
Kandula S; Zhu X; Garden AS; Gillin M; Rosenthal DI; Ang KK; Mohan R; Amin MV; Garcia JA; Wu R; Sahoo N; Frank SJ
Med Dosim; 2013; 38(4):390-4. PubMed ID: 23916884
[TBL] [Abstract][Full Text] [Related]
20. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
